Supha Pharmachem Limited - Company Profile

Q: Who are the current directors of Supha Pharmachem Limited?

The current directors of Supha Pharmachem Limited are Vijay Pal Singh Gulya, Mansoor Vahab, Bikram Kumar Mund, Ashish Dinanath Parkar, Seema Sanei, Hanosh Sam Santok, Adarsh Deepak Munjal, Shamim Adil Michal, Dipesh Vinod Vaidya, Vignesh Laxman Gawde, Rambhajan Vishwakarma.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1988.

1988 Mumbai, Maharashtra, India Active

Last Updated: January 06, 2026

Access Report

About Supha Pharmachem Limited

Supha Pharmachem Limited, a active public limited company, was established on 19 February 1988 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: L24100MH1988PLC343805. Registered under ROC Roc Mumbai. it is listed on BSE: 539561. It has an authorized capital of ₹110.00 Cr and a paid-up capital of ₹88.20 Cr.

Formerly known as Roxy Exports Limited, Supha Pharmachem Limited. It upholds a compliant status. In 2023, it reported revenue of ₹509.84 Cr and a net worth of ₹10.36 Cr. Employing 6 professional, Its leadership includes Vijay Pal Singh Gulya (Director), Mansoor Vahab (Director), Bikram Kumar Mund (Director). Past directors included Vijay Pal Singh Gulya, Trupti Madhukar Bolke, Mansoor Vahab. It holds no open charges and ₹3.26 Cr settled loans. Its latest AGM occurred on 24 September 2025, with the balance sheet filed on 31 March 2025. It is based at Office No.9, K Raheja Prime, Marol Industrial Estate, Behind Ravi Vihar Hotel, Sagbaug Road,Marol, Andheri East, Mumbai, Maharashtra, 400059.

Company Details

CIN/LLPIN
L24100MH1988PLC343805
Registration Number
343805
Incorporation Date
19 February 1988
Authorized Capital
₹110.00 Cr
Paid-Up Capital
₹88.20 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 539561)
Company Status
Active

Key Metrics

Authorised Capital ₹ 110.00 Cr as on 06-01-2026
Paid Up Capital ₹ 88.20 Cr as on 06-01-2026
Company Age 38 Year, 1 Month
Last Filing with ROC 31 Mar 2025
Satisfied Charges ₹ 3.26 Cr as on 06-01-2026
Revenue Growth **** 1.00% (FY 2023)
Profit Growth **** 403.44% (FY 2023)
Ebitda **** 337.97% (FY 2023)
Net Worth 109.88% (FY 2023)
Total Assets **** 415.84% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Supha Pharmachem Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Supha Pharmachem Limited?

Current Directors

Name	Designation	Appointment Date	Status
Vijay Pal Singh Gulya	Director	30 May 2025	Current
Mansoor Vahab	Director	31 Oct 2024	Current
Bikram Kumar Mund	Director	30 May 2025	Current
Seema Sanei	Additional Director	11 Apr 2024	Current
Hanosh Sam Santok	Director	30 Sep 2019	Current
Adarsh Deepak Munjal	Director	05 Sep 2023	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	11 Aug 2025	Past
Pramod Abcsdd	Director	31 Oct 2024	Past
Pramod Abcsdd	Additional Director	21 Jan 2025	Past
Pramod Abcsdd	Additional Director	30 Sep 2021	Past
Pramod Abcsdd	Additional Director	11 Aug 2025	Past
Pramod Abcsdd	Company Secretary	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Supha Pharmachem.

Remedium Lifecare Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1% increase. The company also saw a substantial improvement in profitability, with a 403.44% increase in profit. The company's net worth Soared by an impressive increase of 109.88%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

1.00%

*******

Revenue from Operations

*******

1.00%

*******

Total Assets

*******

415.84%

*******

Profit or Loss

*******

403.44%

*******

Net Worth

*******

109.88%

*******

EBITDA

*******

337.97%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Supha Pharmachem?

In 2023, Supha Pharmachem had a promoter holding of 1.11% and a public holding of 98.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹32,614,000.00

Charges Breakdown by Lending Institutions

Indian Overseas Bank : 2.45 Cr
Punjab National Bank : 0.50 Cr
Punjab Financial Corporation : 0.23 Cr
Industrial Centre : 0.09 Cr

Latest Charge Details

Date	Lender	Amount	Status
09 Mar 2012	Indian Overseas Bank	₹9.50 M	Satisfied
07 Jan 2011	Indian Overseas Bank	₹1.50 Cr	Satisfied
20 Feb 1996	Punjab National Bank	₹0.60 M	Satisfied
02 Aug 1995	Punjab National Bank	₹0.25 M	Satisfied
24 Apr 1995	Punjab National Bank	₹1.50 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Supha Pharmachem?

Supha Pharmachem has a workforce of 6 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Supha Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supha Pharmachem's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Supha Pharmachem

Recent Activity within the Organization

Director Appointment

The activity Vignesh Laxman Gawde was appointed as a Whole-time director was appointed as a Whole-time director on 31 Oct 2025 & has been associated with this company since 4 months 30 days . was completed.
31 Oct 2025
Director Appointment

Rambhajan Vishwakarma was appointed as a Director was appointed as a Director on 31 Oct 2025 & has been associated with this company since 4 months 30 days . was recorded as a recent event.
31 Oct 2025
Annual General Meeting

The activity Supha Pharmachem Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records. was completed.
24 Sep 2025
Director Appointment

Vijay Pal Singh Gulya was appointed as a Director was appointed as a Director on 30 May 2025 & has been associated with this company since 10 months . was recorded as a recent event.
30 May 2025
Director Appointment

The activity Bikram Kumar Mund was appointed as a Director was appointed as a Director on 30 May 2025 & has been associated with this company since 10 months . was completed.
30 May 2025
Balance Sheet

Progress on Supha Pharmachem Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
31 Mar 2025

Explore recent activity and updates - View Recent Activity